Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. The company is headquartered in West Conshohocken, Pennsylvania.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -2865.00% |
| Return on Assets | -278.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.03 |
| Price-to-Book | 14.42 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $56.66M |
| Float | $50.14M |
| % Insiders | 12.83% |
| % Institutions | 4.10% |
Volatility is currently contracting